Everest Group Ltd. (NYSE:EG) is a key player in reinsurance and specialty insurance with significant growth potential across multiple continents. The company is known for its strong underwriting discipline and stability despite market fluctuations, maintaining a solid balance sheet. Everest is undervalued

Meritage Homes’ stock fell 23% over the past three months, but solid financial health signals potential for dividends. The company boasts a 15% Return on Equity (ROE), aligning closely with industry averages, supporting strong growth. A lean payout ratio of 6.3% suggests

Lucid Group’s stock price fell below $3 due to an analyst downgrade by Tobias Beith of Redburn Atlantic, reducing the recommendation from “neutral” to “sell”. The new price target is $1.13 per share, significantly lower than the previous target and 63% below

Axsome Therapeutics experienced a revenue surge of 43% to $385.7 million but faced a net loss of $287.2 million, reflecting a 20% drop from the previous year. Earnings per share decreased significantly to a loss of $5.99, with 98% of revenues drawn